Kyntra Bio to Report Second Quarter 2026 Financial Results
Go back to Kyntra Bio to Report Second Quarter 2026 Financial Results| (NASDAQ: KYNB) | Delayed: 3.96 -0.35 (8.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.31 | 52 Week High | $ | |||
| Open | $4.46 | 52 Week Low | $ | |||
| Day High | $4.87 | P/E | N/A | |||
| Day Low | $3.96 | EPS | $ | |||
| Volume | 17,625 | |||||



